Table 2.
Testosterone Values at the Time of CRFS Progression Events (mITT population).
|
Testosterone Values at the Time of
CRFS Progression Events |
||
|---|---|---|
| Testosterone Values (ng/dL) |
Relugolix a
(N = 717) |
Leuprolide a
(N = 357) |
| 0 to ≤10 | 33 | 22 + 4 died |
| 10 to ≤20 | 43 | 13 + 1 died |
| 20 to ≤30 | 7 + 1 died | 0 |
| 30 to ≤40 | 1 | 0 |
| 40 to ≤50 | 3 | 0 |
| >50 | 0 | 2 died b |
Abbreviations: CRFS = castration resistance-free survival; mITT = modified intention-to-treat. a For men who died, the last testosterone values measured before death were used. b Both patients died with last testosterone >100 ng/dL.